| Indicators | Browse All

CDT Equity Inc. (CDT)

Healthcare | Biotechnology | Naples, United States | NasdaqCM
0.36 USD -0.02 (-5.929%) ⇩ (July 13, 2026, 4 p.m. EDT)
After hours: 0.36 0.00 (-0.002%) ⇩ (July 13, 2026, 7:43 p.m. EDT)

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 6:55 a.m. EDT

The immediate outlook is severely bearish as the stock has collapsed from recent highs of $1.50 to current levels near $0.38, reflecting a brutal sell-off over the last two weeks. While headlines celebrate a patent win and a stake in Sarborg Quantum, these catalysts failed to arrest the bleeding, suggesting the market views the company's massive debt load and negative book value as existential threats that outweigh any potential upside. The statistical forecast model predicts a further 19% drop over the next 45 days, though its very low confidence suggests this is merely noise; however, the technical reality remains a steep decline. Looking further out, the business fundamentals are deteriorating rapidly, evidenced by a nearly 99.98% loss of value over the past three years and two consecutive years of negative annual returns. The company is burning cash with negative operating flows and a negative book value, indicating that the equity is technically underwater. Despite the recent news of debt restructuring, the trajectory shows a structural implosion rather than a turnaround. Finally, there is absolutely no dividend support here; the company has paid nothing in the last five years, offering zero income to investors.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.198560
MSTL0.250947
AutoETS0.278667
AutoTheta0.425555

Forecast horizon: 60 days | Selected: AutoARIMA

Forecast Reliability
Score 21%
H-stat 10.63
Ljung-Box p 0.000
Jarque-Bera p 0.000
Excess Kurtosis 3.89
Attribute Value
Sector Healthcare
Market Cap 1,742,204
Beta 1.46
Previous Name Conduit Pharmaceuticals Inc.
Website https://www.cdtequity.com

Info Dump

Attribute Value
52 Week Change -0.9991753
Address1 4,581 Tamiami Trail North
Address2 Suite 200
All Time High 7,500,000.0
All Time Low 0.38
Ask 0.4442
Ask Size 2
Average Daily Volume10 Day 629,240
Average Daily Volume3 Month 7,149,247
Average Volume 7,149,247
Average Volume10Days 629,240
Beta 1.457
Bid 0.273
Bid Size 2
Book Value -77.816
City Naples
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.3586
Current Ratio 0.342
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 0.39
Day Low 0.3416
Display Name CDT Equity
Earnings Timestamp End 1,762,977,600
Earnings Timestamp Start 1,762,977,600
Ebitda -24,738,000
Ebitda Margins 0.0
Enterprise To Ebitda -0.041
Enterprise Value 1,008,228
Eps Trailing Twelve Months -1,177.89
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.14564
Fifty Day Average Change -0.78704
Fifty Day Average Change Percent -0.68698716
Fifty Two Week Change Percent -99.917534
Fifty Two Week High 492.0
Fifty Two Week High Change -491.6414
Fifty Two Week High Change Percent -0.9992711
Fifty Two Week Low 0.3416
Fifty Two Week Low Change 0.01699999
Fifty Two Week Low Change Percent 0.049765777
Fifty Two Week Range 0.3416 - 492.0
Financial Currency USD
First Trade Date Milliseconds 1,648,474,200,000
Float Shares 2,259,990
Free Cashflow 5,220,750
Full Exchange Name NasdaqCM
Full Time Employees 4
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.35091
Held Percent Institutions 0.00208
Implied Shares Outstanding 4,858,350
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,774,569,600
Last Split Factor 1:25
Long Business Summary CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Long Name CDT Equity Inc.
Market us_market
Market Cap 1,742,204
Market State POSTPOST
Max Age 86,400
Message Board Id finmb_1772079937
Most Recent Quarter 1,767,139,200
Name Change Date 2,026-07-13
Net Income To Common -39,224,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 1,856,132
Open 0.39
Operating Cashflow -15,555,000
Operating Margins 0.0
Payout Ratio 0.0
Phone 646 491 9132
Post Market Change -0.0015999973
Post Market Change Percent -0.44617885
Post Market Price 0.357
Post Market Time 1,783,986,239
Prev Name Conduit Pharmaceuticals Inc.
Previous Close 0.3812
Price Hint 4
Price To Book -0.0046083066
Profit Margins 0.0
Quick Ratio 0.118
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0226
Regular Market Change Percent -5.92865
Regular Market Day High 0.39
Regular Market Day Low 0.3416
Regular Market Day Range 0.3416 - 0.39
Regular Market Open 0.39
Regular Market Previous Close 0.3812
Regular Market Price 0.3586
Regular Market Time 1,783,972,801
Regular Market Volume 363,522
Return On Assets -3.4495301
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 4,858,350
Shares Percent Shares Out 0.0345
Shares Short 167,688
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 53,538
Short Name CDT Equity Inc.
Short Percent Of Float 0.0659
Short Ratio 0.01
Source Interval 15
State FL
Symbol CDT
Total Cash 1,509,000
Total Cash Per Share 0.311
Total Debt 775,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1,177.89
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 33.48041
Two Hundred Day Average Change -33.12181
Two Hundred Day Average Change Percent -0.9892892
Type Disp Equity
Volume 363,522
Website https://www.cdtequity.com
Zip 34,103